Psoriatic arthritis
https://doi.org/10.51523/2708-6011.2023-20-3-16
Abstract
Psoriasis is a chronic non-infectious autoimmune disease, dermatosis, affecting mainly the skin. Usually psoriasis is manifested by the formation of red, excessively dry, raised spots above the surface of the skin — the so-called papules, which merge with each other, forming plaques. These papules by their nature are the sites of chronic inflammation and excessive proliferation of lymphocytes, macrophages and keratinocytes of the skin, as well as excessive angiogenesis.
Psoriatic arthritis (arthopathic psoriasis) is a chronic inflammatory disease of the joints, spine and entheses, which can be observed in patients with psoriasis.
The article presents a clinical case of psoriatic arthritis. The analysis of literature sources, clinical data, and laboratory results was carried out.
About the Authors
T. A. KurmanBelarus
Tatyana A. Kurman, Assistant of the Department of Internal Diseases №.1 with courses of Endocrinology and Hematology
Gomel
E. G. Malaeva
Belarus
Ekaterina G. Malaeva, Candidate of Medical Sciences, Associate Professor, Head of the Department of of Internal Diseases №1 with courses of Endocrinology and Hematology
Gomel
E. V. Tsitko
Belarus
Ekaterina V. Tsitko, Candidate of Medical Sciences, Associate Professor, Associate Professor of the Department of of Internal Diseases №1 with courses of Endocrinology and
Hematology
Gomel
I. V. Liakhno
Belarus
Inna V. Liakhno, Head of the Therapeutic Department
Gomel
M. A. Feshchanka
Belarus
Maryna A. Feshchanka, Anesthesiologist-Resuscitator
Gomel
E. E. Karpenko
Belarus
Elena E. Karpenko, Chief City Rheumatologist, Rheumatologist
Gomel
References
1. Sidorchik TG, Linev VA, Radzinya MA, Rubins Aya, Rubins SA. Enthesitis and psoriatic onychopathy as predisposing factors of psoriatic arthritis in patients with psoriasis. Bulletin of Dermatology and Venereology. 2018;(1):38-50.
2. Svechnikova EV, Zhufina SE. Experience of using secukinumab in a patient with widespread severe vulgar psoriasis and psoriatic arthritis. Clinical dermatology and venereology. 2018;17(3):97-102. DOI: https://doi.org/10.17116/klinderma2018173103
3. Bakulev AL. Blockers of signaling pathways: mechanism of action, efficacy, safety of therapy in patients with psoriasis and psoriatic arthritis. Bulletin of Dermatology and Venereology. 2018;(5):89-96.
4. Smolen JS, Schöls M, Braun J, Dougados M, FitzGerald O, et al. Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force. Ann Rheum Dis. 2018 Jan;77(1):3-17. DOI: https://doi.org/10.1136/annrheumdis-2017-211734
5. Bakulev AL, Fitileva TV, Novoderezhkina EA, et al. Psoriasis: Clinico-extravepidemiological features and treatments. Journal of Dermatology and Venereology. 2018;94(3):67-76.
6. Klingberg E, Bilberg A, Björkman S, Hedberg M, Jacobsson L, et al. Weight loss improves disease activity in patients with psoriatic arthritis and obesity: an interventional study. Arthritis Res Ther. 2019 Jan 11;21(1):17. DOI: https://doi.org/10.1186/s13075-019-1810-5
7. Gaidukova IZ, Rebrov AP, Lebedinskaya OA, Akulova A.I. Aparkina, A.V. Cardiovascular morbidity and mortality in ankylosing spondylitis and psoriatic arthritis - results of a single-center four-year follow-up. Practical medicine. 2015;(2):123-129.
8. Markelova EI, Novikova DS, Korotaeva TV, Loginova EYu, Kirillova IG. The prevalence of traditional cardiovascular risk factors, subclinical carotid atherosclerosis, coronary artery calcification in patients with early psoriatic arthritis (a remarca study). Rheumatology Science and Practice. 2018;56(2):184-188. (In Russ.). DOI: https://doi.org/10.14412/1995-4484-2018-184-188
9. McGonagle D, Eshed I. MRI. In: FitzGerald O, Gladman D, eds. Oxford textbook of psoriatic arthritis. Oxford, UK: Oxford University Press; 2018; P. 165-175.
10. Kubanova AA, Kubanov AA, Nasonov EL, Sokolovsky EV, Znamenskaya LF, et al. Psoriatic arthritis. Clinical recommendations of the RODVC and the Association of Rheumatologists of Russia. M.; 2016. p. 471.
11. Yusupova LA, Filatova MA. The current state of the problem of psoriatic arthritis. Practical medicine. 2013;(3):24-28.
12. Alinaghi F, Calov M, Kristensen LE, Gladman DD, Coates LC, et al. Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies. J Am Acad Dermatol. 2019 Jan;80(1):251-265.e19. DOI: https://doi.org/10.1016/j.jaad.2018.06.027
13. Scotti L, Franchi M, Marchesoni A, Corrao G. Prevalence and incidence of psoriatic arthritis: A systematic review and metaanalysis. Semin Arthritis Rheum. 2018 Aug;48(1):28-34. DOI: https://doi.org/10.1016/j.semarthrit.2018.01.003
Review
For citations:
Kurman T.A., Malaeva E.G., Tsitko E.V., Liakhno I.V., Feshchanka M.A., Karpenko E.E. Psoriatic arthritis. Health and Ecology Issues. 2023;20(3):123-128. (In Russ.) https://doi.org/10.51523/2708-6011.2023-20-3-16